
This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.
To own Pennant Group, you have to believe that aging demographics and the shift toward lower cost home health and hospice care can support steady, profitable growth, despite heavy exposure to government reimbursement. The latest US$288,000,000 revenue result supports the demand side of that story, but the muted share price reaction suggests near term focus may stay on 2026 reimbursement risk and integration execution. Overall, this news strengthens the growth catalyst, while the key policy risk remains largely unchanged for now.
The most relevant recent announcement is Pennant’s 2026 revenue guidance of US$1,133.6 million to US$1,171.8 million, issued alongside the record 2025 results. This outlook sits directly against concerns about a potential 6.4% CMS home health payment cut, making guidance an important reference point for how management currently views volume growth and pricing versus reimbursement pressure. For investors, how actual results track against this range could quickly influence confidence in Pennant’s growth narrative.
Yet beneath the solid headline revenue growth, investors still need to be aware of the company’s high dependence on shifting Medicare and Medicaid policy...
Read the full narrative on Pennant Group (it's free!)
Pennant Group's narrative projects $1.3 billion revenue and $68.1 million earnings by 2029. This requires 10.9% yearly revenue growth and about a 2.3x earnings increase from $29.6 million today.
Uncover how Pennant Group's forecasts yield a $37.83 fair value, a 28% upside to its current price.
Some of the most optimistic analysts were already penciling in about US$1.3 billion in revenue and US$60.0 million in earnings within a few years, which is far more upbeat than consensus, and your view on whether Pennant’s recent revenue beat offsets the risk of tighter government reimbursement could leave you closer to that camp or much more cautious.
Explore 5 other fair value estimates on Pennant Group - why the stock might be worth 38% less than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com